Home hemodialysis, particularly when delivered more frequently, is shown to significantly improve patients' quality-of-life and other important clinical outcomes. Because traditional in-center ...
LAWRENCE, Mass., Oct. 5, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on a review article published on October 4 ...
LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a ...
NxStage Medical, Inc. NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...
LAWRENCE, Mass., Dec. 11, 2017 /CNW/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, celebrates the achievement of over five thousand ...
NxStage Medical, Inc. (NASDAQ:NXTM) announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure or conversion to in-center hemodialysis by ...
NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...